Promotion of wakefulness and energy expenditure by orexin-a in the ventrolateral preoptic area

Sleep

Volumn 38, Issue 9, 2015, Pages 1361-1370

  Mavanji, Vijayakumar ^d   Perez Leighton, Claudio E ^f   Kotz, Catherine M ^d,e,g,i   Billington, Charles J ^d,g,h,i   Parthasarathy, Sairam ^b,c   Sinton, Christopher M ^b,c   Teske, Jennifer A ^a,d,g,i  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d VA MEDICAL CENTER   (United States)

^e GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^f UNIVERSIDAD ANDRÉS BELLO   (Chile)

^g University of Minnesota   (United States)

^h UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Arousal; Brain; Obesity; Sleep

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; OREXIN; OREXIN 2 RECEPTOR; OREXIN 2 RECEPTOR ANTAGONIST; OREXIN A; OREXIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; 1 (2,4 DIBROMOPHENYL) 3 (2,2 DIMETHYL 4 PHENYL 1,3 DIOXAN 5 YL)UREA; CARBANILAMIDE DERIVATIVE; DIOXANE DERIVATIVE; OREXIN RECEPTOR;

ALERTNESS; ANIMAL EXPERIMENT; AROUSAL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ENERGY BALANCE; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FOOD INTAKE; GROOMING; LUNG GAS EXCHANGE; MALE; NEUROMODULATION; NONHUMAN; NONREM SLEEP; OBESITY; PHYSICAL ACTIVITY; PREOPTIC AREA; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP TIME; SLEEP WAKING CYCLE; VENTROLATERAL PREOPTIC AREA; WAKEFULNESS; ANIMAL; ATTENTION; CYTOLOGY; DRUG EFFECTS; EATING; ENERGY METABOLISM; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SLEEP; SLEEP DEPRIVATION; SPRAGUE DAWLEY RAT; TIME FACTOR;

ANIMALS; ATTENTION; DIOXANES; EATING; ENERGY METABOLISM; MALE; NEURONS; OREXIN RECEPTOR ANTAGONISTS; OREXIN RECEPTORS; OREXINS; PHENYLUREA COMPOUNDS; PREOPTIC AREA; RATS; RATS, SPRAGUE-DAWLEY; SLEEP; SLEEP DEPRIVATION; TIME FACTORS; WAKEFULNESS;

EID: 84940736139     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.4970     Document Type: Article

References (82)

1. Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 2008;1129:287-304.
2. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and allcause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010;33:585-92.
3. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010;33:414-20.
4. Patel SR, Hu FB. Short sleep duration and weight gain: a systematic review. Obesity 2008;16:643-53.
5. Jean-Louis G, Williams NJ, Sarpong D, et al. Associations between inadequate sleep and obesity in the US adult population: analysis of the national health interview survey (1977-2009). BMC Public Health 2014;14:290.
6. St-Onge MP. The role of sleep duration in the regulation of energy balance: effects on energy intakes and expenditure. J Clin Sleep Med 2013;9:73-80.
7. Penev PD. Update on energy homeostasis and insufficient sleep. J Clin Endocrinol Metab 2012;97:1792-801.
8. Shlisky JD, Hartman TJ, Kris-Etherton PM, Rogers CJ, Sharkey NA, Nickols-Richardson SM. Partial sleep deprivation and energy balance in adults: an emerging issue for consideration by dietetics practitioners. J Acad Nutr Diet 2012;112:1785-97.
9. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamusspecific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998;95:322-7.
10. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573-85.
11. Giardino WJ, de Lecea L. Hypocretin (orexin) neuromodulation of stress and reward pathways. Curr Opin Neurobiol 2014;29C:103-8.
12. Burdakov D, Karnani MM, Gonzalez A. Lateral hypothalamus as a sensor-regulator in respiratory and metabolic control. Physiol Behav 2013;121:117-24.
13. Sakurai T, Mieda M, Tsujino N. The orexin system: roles in sleep/wake regulation. Ann N Y Acad Sci 2010;1200:149-61.
14. Kotz C, Nixon J, Butterick T, Perez-Leighton C, Teske J, Billington C. Brain orexin promotes obesity resistance. Ann N Y Acad Sci 2012;1264:72-86.
15. Li J, Hu Z, de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol 2014;171:332-50.
16. Berthoud HR, Munzberg H. The lateral hypothalamus as integrator of metabolic and environmental needs: from electrical self-stimulation to opto-genetics. Physiol Behav 2011;104:29-39.
17. Lee MG, Hassani OK, Jones BE. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 2005;25:6716-20.
18. Taheri S, Sunter D, Dakin C, et al. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neurosci Lett 2000;279:109-12.
19. Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005;46:787-98.
20. Hagan JJ, Leslie RA, Patel S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A 1999;96:10911-6.
21. Kotz CM, Teske JA, Levine JA, Wang C. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul Pept 2002;104:27-32.
22. Kotz CM, Teske JA, Billington CJ. Neuroregulation of nonexercise activity thermogenesis and obesity resistance. Am J Physiol Regul Integr Comp Physiol 2008;294:R699-710.
23. Lubkin M, Stricker-Krongrad A. Independent feeding and metabolic actions of orexins in mice. Biochemical and biophysical research communications 1998;253:241-5.
24. Novak CM, Levine JA. Daily intraparaventricular orexin-A treatment induces weight loss in rats. Obesity 2009;17:1493-8.
25. Perez-Leighton CE, Boland K, Billington CJ, Kotz CM. High and low activity rats: elevated intrinsic physical activity drives resistance to diet-induced obesity in non-bred rats. Obesity 2013;21:353-60.
26. Sherin JE, Shiromani PJ, McCarley RW, Saper CB. Activation of ventrolateral preoptic neurons during sleep. Science 1996;271:216-9.
27. Lu J, Greco MA, Shiromani P, Saper CB. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci 2000;20:3830-42.
28. Szymusiak R, Alam N, Steininger TL, McGinty D. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res 1998;803:178-88.
29. Szymusiak R, McGinty D. Hypothalamic regulation of sleep and arousal. Ann N Y Acad Sci 2008;1129:275-86.
30. Szymusiak R, McGinty D. Sleep-related neuronal discharge in the basal forebrain of cats. Brain Res 1986;370:82-92.
31. Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001;24:726-31.
32. Sherin JE, Elmquist JK, Torrealba F, Saper CB. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 1998;18:4705-21.
33. Novak CM, Nunez AA. Daily rhythms in Fos activity in the rat ventrolateral preoptic area and midline thalamic nuclei. Am J Physiol 1998;275:R1620-6.
34. Marcus JN, Aschkenasi CJ, Lee CE, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001;435:6-25.
35. Mavanji V, Teske JA, Billington CJ, Kotz CM. Elevated sleep quality and orexin receptor mRNA in obesity-resistant rats. Int J Obes (Lond) 2010;34:1576-88.
36. Berk ML, Finkelstein JA. Efferent connections of the lateral hypothalamic area of the rat: an autoradiographic investigation. Brain Res Bull 1982;8:511-26.
37. Chou TC, Bjorkum AA, Gaus SE, Lu J, Scammell TE, Saper CB. Afferents to the ventrolateral preoptic nucleus. J Neurosci 2002;22:977-90.
38. Novak CM, Nunez AA. A sparse projection from the suprachiasmatic nucleus to the sleep active ventrolateral preoptic area in the rat. Neuroreport 2000;11:93-6.
39. Yoshida K, McCormack S, Espana RA, Crocker A, Scammell TE. Afferents to the orexin neurons of the rat brain. J Comp Neurol 2006;494:845-61.
40. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.
41. Date Y, Ueta Y, Yamashita H, et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A 1999;96:748-53.
42. Gaus SE, Strecker RE, Tate BA, Parker RA, Saper CB. Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species. Neuroscience 2002;115:285-94.
43. Sakurai T, Nagata R, Yamanaka A, et al. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 2005;46:297-308.
44. Methippara MM, Alam MN, Szymusiak R, McGinty D. Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuroreport 2000;11:3423-6.
45. Paxinos G, Watson C, Pennisi M, Topple A. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J Neurosci Methods 1985;13:139-43.
46. Cleary JP, O'Hare E, Pomonis JD, et al. Discriminative stimulus effects of morphine: central versus peripheral training. Brain Res 1999;847:26-31.
47. O'Hare E, Cleary J, Weldon DT, Pomonis JD, Billington CJ, Levine AS. Intrahypothalamic discriminative stimulus effects of neuropeptide Y. Pharmacol Biochem Behav 1998;59:375-8.
48. Teske JA, Billington CJ, Kotz CM. Mechanisms underlying obesity resistance associated with high spontaneous physical activity. Neuroscience 2014;256:91-100.
49. Nicholson C. Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity. Brain Res 1985;333:325-9.
50. Grosse P, Cassidy MJ, Brown P. EEG-EMG, MEG-EMG and EMGEMG frequency analysis: physiological principles and clinical applications. Clin Neurophysiol 2002;113:1523-31.
51. Teske JA, Levine AS, Kuskowski M, Levine JA, Kotz CM. Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 2006;291:R889-99.
52. Winrow CJ, Tanis KQ, Reiss DR, et al. Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacology 2010;58:185-94.
53. Broom DM. Animal welfare: concepts and measurement. J Anim Sci 1991;69:4167-75.
54. Dugovic C, Shelton JE, Aluisio LE, et al. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J Pharmacol Exp Ther 2009;330:142-51.
55. Adamantidis A, de Lecea L. The hypocretins as sensors for metabolism and arousal. J Physiol 2009;587:33-40.
56. Sinton CM. Orexin/hypocretin plays a role in the response to physiological disequilibrium. Sleep Med Rev 2011;15:197-207.
57. Sinton CM, McCarley RW. Neurophysiological mechanisms of sleep and wakefulness: a question of balance. Semin Neurol 2004;24:211-23.
58. Teske JA, Billington CJ, Kotz CM. Neuropeptidergic mediators of spontaneous physical activity and non-exercise activity thermogenesis. Neuroendocrinology 2008;87:71-90.
59. Leranth C, MacLusky NJ, Shanabrough M, Naftolin F. Immunohistochemical evidence for synaptic connections between propiomelanocortin-immunoreactive axons and LH-RH neurons in the preoptic area of the rat. Brain Res 1988;449:167-76.
60. Saper CB, Fuller PM, Pedersen NP, Lu J, Scammell TE. Sleep state switching. Neuron 2010;68:1023-42.
61. Williams RH, Chee MJ, Kroeger D, et al. Optogenetic-mediated release of histamine reveals distal and autoregulatory mechanisms for controlling arousal. J Neurosci 2014;34:6023-9.
62. Gong H, McGinty D, Guzman-Marin R, Chew KT, Stewart D, Szymusiak R. Activation of c-fos in GABAergic neurones in the preoptic area during sleep and in response to sleep deprivation. J Physiol 2004;556:935-46.
63. Novak CM, Kotz CM, Levine JA. Central orexin sensitivity, physical activity, and obesity in diet-induced obese and diet-resistant rats. Am J Physiol Endocrinol Metab 2006;290:E396-403.
64. Kiwaki K, Kotz CM, Wang C, Lanningham-Foster L, Levine JA. Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am J Physiol Endocrinol Metab 2004;286:E551-9.
65. Teske JA, Perez-Leighton CE, Billington CJ, Kotz CM. Role of the locus coeruleus in enhanced orexin A-induced spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 2013;305:R1337-45.
66. Thorpe AJ, Mullett MA, Wang C, Kotz CM. Peptides that regulate food intake: regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation. Am J Physiol Regul Integr Comp Physiol 2003;284:R1409-17.
67. Espana RA, Plahn S, Berridge CW. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res 2002;943:224-36.
68. de Lecea L, Sutcliffe JG, Fabre V. Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides 2002;36:85-95.
69. Thorpe AJ, Doane DF, Sweet DC, Beverly JL, Kotz CM. Orexin A in the rostrolateral hypothalamic area induces feeding by modulating GABAergic transmission. Brain Res 2006;1125:60-6.
70. van den Pol AN, Gao XB, Obrietan K, Kilduff TS, Belousov AB. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 1998;18:7962-71.
71. Alam MN, Kumar S, Bashir T, et al. GABA-mediated control of hypocretin- but not melanin-concentrating hormone-immunoreactive neurones during sleep in rats. J Physiol 2005;563:569-82.
72. Alam MN, Kumar S, Suntsova N, Bashir T, Szymusiak R, McGinty D. GABAergic regulation of the perifornical-lateral hypothalamic neurons during non-rapid eye movement sleep in rats. Neuroscience 2010;167:920-8.
73. Burdakov D, Liss B, Ashcroft FM. Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium-calcium exchanger. J Neurosci 2003;23:4951-7.
74. Williams RH, Jensen LT, Verkhratsky A, Fugger L, Burdakov D. Control of hypothalamic orexin neurons by acid and CO2. Proc Natl Acad Sci U S A 2007;104:10685-90.
75. Yamanaka A, Beuckmann CT, Willie JT, et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003;38:701-13.
76. Moriguchi T, Sakurai T, Nambu T, Yanagisawa M, Goto K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci Lett 1999;264:101-4.
77. Mieda M, Williams SC, Sinton CM, Richardson JA, Sakurai T, Yanagisawa M. Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. J Neurosci 2004;24:10493-501.
78. Bergman JM, Roecker AJ, Mercer SP, et al. Proline bis-amides as potent dual orexin receptor antagonists. Bioorg Med Chem Lett 2008;18:1425-30.
79. Samson WK, Bagley SL, Ferguson AV, White MM. Orexin receptor subtype activation and locomotor behaviour in the rat. Acta Physiol (Oxf) 2010;198:313-24.
80. Winrow CJ, Gotter AL, Cox CD, et al. Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist. J Neurogenet 2011;25:52-61.
81. Arrigoni E, Mochizuki T, Scammell TE. Activation of the basal forebrain by the orexin/hypocretin neurones. Acta Physiol (Oxf) 2010;198:223-35.
82. Kotz CM, Glass MJ, Levine AS, Billington CJ. Regional effect of naltrexone in the nucleus of the solitary tract in blockade of NPY-induced feeding. Am J Physiol Regul Integr Comp Physiol 2000;278:R499-503.